Linda Cheng

Title: Linda Cheng: Innovator in Urinary Frequency Disorders

Introduction

Linda Cheng is a notable inventor based in West Nyack, NY (US). She has made significant contributions to the field of medicine, particularly in the treatment of urinary frequency disorders. With a total of 2 patents to her name, her work focuses on innovative methods and compositions that enhance patient care.

Latest Patents

Linda Cheng's latest patents include two groundbreaking inventions. The first patent is titled "Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist." This invention provides methods and compositions for the use of desmopressin in combination with an alpha-adrenergic receptor antagonist, which is useful in the treatment of nocturia and other urinary frequency disorders. The second patent is "Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor." This invention also focuses on the use of desmopressin in combination with a 5-alpha reductase inhibitor, aimed at treating nocturia and similar conditions.

Career Highlights

Linda Cheng is currently associated with Serenity Pharmaceuticals LLC, where she continues to develop her innovative ideas. Her work has been instrumental in advancing treatment options for patients suffering from urinary frequency disorders.

Collaborations

Some of her notable coworkers include Seymour H Fein and Maria Cheng, who contribute to her research and development efforts.

Conclusion

Linda Cheng's contributions to the field of medicine through her patents demonstrate her commitment to improving patient outcomes in urinary frequency disorders. Her innovative approaches are paving the way for more effective treatments.